FRONTIER BIOTECHNOLOGIES Inc.

R&D

FRONTIER BIOTECHNOLOGIES Inc
Home>R&D>R&D

Core area

Leading Biopharmaceutical (Nanjing) Co., Ltd. has independently established a “long-acting peptide new drug development platform” with global patents to solve the two technical problems of short-term half-life of conventional peptide drugs and possible immunogenicity, in order to develop long-acting peptides. New drug. In line with this, we have established a professional team that can carry out complex peptide chemical synthesis, process optimization, amplification and industrialization technology research. We have established a raw material drug synthesis and preparation production facility from milligrams to kilograms, and sustainable development of a series of new peptide drugs. Welcome Domestic and foreign companies come to discuss cooperation.

research project



Leading-edge organisms have always insisted on independent innovation and established a “long-acting peptide new drug development platform” with global patents. This technology can solve the two technical problems of short-term half-life of conventional peptide drugs and possibly lead to immunogenicity, so as to develop new drugs with intellectual property rights. In conjunction with this, a professional team that can carry out complex peptide chemical synthesis, process optimization, amplification and industrialization technology research has been set up. The raw material drug synthesis and preparation production facilities from milligrams to kilograms have been established, and a series of new peptide drugs have been developed.

Innovative solutions to promote human health